Here are the top health news for the day:
'Inhumane Torture' and ragging horror at SVN medical college, junior residents made to stand continuously, refused hostel rooms
An instance of "inhumane torture" and "ragging" has come up in Maharashtra's Yavatmal district as a complaint has been filed in this regard alleging ragging of a Junior Resident first year student of MS General Surgery at Shri Vasantrao Naik (SVN) Medical College by his seniors,
Writing to the Dean of the Medical College, the guardian of the PG medico has alleged that the third-year Junior resident doctors have been causing physical and mental torture to the first-year medico by several means.
For more details, check out the link given below:
NMC directs all medical colleges to implement Pradhan Mantri National Dialysis Portal
Through a recent notice, the National Medical Commission (NMC) has informed regarding the implementation of the Pradhan Mantri National Dialysis Portal (PMNDP) in all Medical Colleges including both Government and Private.
As per the notice issued by Dr Sandhya Bhullar, NMC Secretary all medical institutes which are providing
For more details, check out the link given below:
NMC directs all medical colleges to implement Pradhan Mantri National Dialysis Portal
Combinations of 45 medicines fixed, including sitagliptin- metformin, linagliptin -metformin combinations
Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed the retail prices of 45 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 100th Authority meeting dated 05.08.2022.
The said formulations include diabetes medications such as Pure & Cure Healthcare and Cadila Pharma's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Torrent Pharma's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Exemed Pharma and Cipla's Sitagliptin and Metformin Hydrochloride (Sustained release) Tablets, Bajaj Healthcare and J.B. Chemicals & Pharmaceuticals's Sitagliptin Phosphate and Metformin Hydrochloride Tablets, MSN Labs and Eris Lifesciences's Linagliptin and Metformin Hydrochloride extended-release Tablet.
For more details, check out the link given below:
SGPGI slapped Rs 39 lakh compensation for negligence, faulty treatment of Late Padma Shri Awardee
Holding the Lucknow based Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) guilty for "negligence and faulty treatment" of eminent artist and Padma Shri awardee Prof Ranbir Singh Bisht, who died around 24 years ago, the State Consumer Disputes Redressal Commission (SCDRC), Uttar Pradesh has directed the Institute to pay Rs 39 lakh compensation.
While considering the complaint by the daughter of the late Padma Shri awardee, the State Consumer Court of Uttar Pradesh has directed SGPGIMS to pay Rs 19 lakh, with interest at a rate of 10 per cent from September 25, 1998, as compensation for negligence and deficiency of service to the complainant.
For more details, check out the link given below:
SGPGI slapped Rs 39 lakh compensation for negligence, faulty treatment of Late Padma Shri Awardee
Only 30% in India reach hospital after a snakebite, shows ICMR study
The apex research regulator, the Indian Council of Medical Research (ICMR) conducting a first-of-its-kind study covering 13 states on incidents, mortality, morbidity and socio-economic burden of snakebites.
The apex research regulator, the Indian Council of Medical Research (ICMR) is carrying out a first-of-its-kind study on incidents of snakebite covering 13 states, including Himachal Pradesh, to gather data on mortality, morbidity and socio-economic burden.
For more details, check out the link given below:
Only 30% in India reach hospital after a snakebite, shows ICMR study
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.